Protein Iron Succinate is a high-performance pharmaceutical intermediate specifically engineered for the effective treatment of iron deficiency anemia. By leveraging a protein-bound iron structure, this compound ensures superior bioavailability and stability, making it an essential component for pharmaceutical formulations targeting both implicit and explicit iron deficiencies.
Indicated for a wide spectrum of clinical needs, Protein Iron Succinate is highly effective for patients suffering from insufficient iron intake, absorption disorders, or chronic blood loss. It is particularly recommended for managing relative iron deficiency anemia associated with critical physiological stages such as pregnancy and lactation, providing a reliable solution for systemic iron replenishment.
Detailed Parameters
| Product Name | Protein Iron Succinate | CAS Number | 93615-44-2 |
|---|---|---|---|
| Chemical Alias | Iron protein succinylate | Classification | Pharmaceutical Intermediates |
| Application | Iron Deficiency Anemia Treatment | Target Use | Oral Solution Formulation |
| Primary Indication | Implicit/Explicit Iron Deficiency | Special Use | Pregnancy & Lactation Anemia |
| Mechanism | Iron replenishment/Absorption enhancement | Purity Grade | Pharmaceutical Grade |
Key Advantages
High Bioavailability
Optimized protein complexing ensures maximum iron absorption rates compared to traditional salts.
Rapid Recovery
Accelerates the restoration of hemoglobin levels in patients with acute blood loss.
Gentle Tolerability
Reduced gastrointestinal irritation, making it ideal for sensitive patients and pregnant women.
Versatile Application
Easily integrated into various oral solution formats for flexible patient dosing.
Clinical Precision
Targeted action for both absolute iron deficiency and relative deficiency states.
Strict Compliance
Manufactured under rigorous pharmaceutical standards ensuring batch-to-batch consistency.
Product Gallery
Management Platforms
API Quality Control
Rigorous testing of raw materials and final intermediates for pharmaceutical purity.
Production Tracking
Full traceability from raw chemical synthesis to final packaging delivery.
Regulatory Compliance
Ensuring all products meet global standards for pharmaceutical intermediates.
Logistics Management
Specialized cold-chain or humidity-controlled shipping for sensitive chemicals.
Inventory Optimization
Smart warehousing ensuring stable supply for large-scale pharmaceutical production.
Technical Support
Expert guidance on formulation and integration of iron succinate into FDF.
Investment Return Comparison
| Performance Metric | Standard Iron Salts | Protein Iron Succinate |
|---|---|---|
| Absorption Rate | Moderate to Low | High / Optimized |
| GI Side Effects | Common (Nausea/Pain) | Minimal / Low |
| Patient Compliance | Moderate | Very High |
| Bioavailability | Variable | Stable & Consistent |
| Clinical Efficacy | Standard | Superior for Chronic Use |
Frequently Asked Questions
It is primarily used as an active pharmaceutical ingredient for treating various types of iron deficiency anemia, including those caused by poor absorption or blood loss.
Its high bioavailability and gentle nature reduce gastrointestinal discomfort, which is critical during pregnancy and lactation periods.
Unlike simple iron salts, the protein-succinylate structure improves the stability of the iron ion and enhances its absorption in the intestinal tract.
Yes, it is indicated for both explicit iron deficiency (low stores) and implicit deficiency (where stores are normal but hemoglobin is low).
The CAS number for Protein Iron Succinate is 93615-44-2.
It is commonly formulated into oral solutions for ease of administration and rapid absorption.
Request a Technical Quote for Protein Iron Succinate
Contact UsRead Our Latest News
Nov.03,2026
Ethylene glycol diacetate: buyer questions on specifications, uses and storage
Find answers about ethylene glycol diacetate, including CAS 111-55-7, EGDA content, acidity, moisture, color, refractive index, uses, and storage conditions.
Read More
Oct.28,2026
Comparing Sevoflurane Options: Specifications, Materials and Supplier Documentation
Compare two Sevoflurane API product listings from Shijiazhuang Kunxiangda Technology Co., Ltd. side by side — covering physical-chemical parameters, USP/EP/CP/GMP standards cited, application scope, material compatibility, and supply-chain documentation.
Read More
